British Health Institute Recommends OFEV for Adults with IPF
Idiopathic Pulmonary Fibrosis, News
Boehringer Ingelheim recently announced that the British National Institute for Health and Care Excellence (NICE) has recommended OFEV (nintedanib) as a therapy for adult patients with idiopathic pulmonary fibrosis (IPF) within the National ... Read more